These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 12588892

  • 1. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.
    Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS.
    J Clin Invest; 2003 Feb; 111(4):539-52. PubMed ID: 12588892
    [Abstract] [Full Text] [Related]

  • 2. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
    Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N.
    J Proteome Res; 2005 Feb; 4(6):2032-42. PubMed ID: 16335948
    [Abstract] [Full Text] [Related]

  • 3. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N, Long H, Zhao M, Yin H, Lu Q.
    Scand J Rheumatol; 2009 Feb; 38(6):464-71. PubMed ID: 19922023
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 5. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
    Reilly CM, Mishra N, Miller JM, Joshi D, Ruiz P, Richon VM, Marks PA, Gilkeson GS.
    J Immunol; 2004 Sep 15; 173(6):4171-8. PubMed ID: 15356168
    [Abstract] [Full Text] [Related]

  • 6. IL-10 regulates murine lupus.
    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J.
    J Immunol; 2002 Aug 15; 169(4):2148-55. PubMed ID: 12165544
    [Abstract] [Full Text] [Related]

  • 7. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S.
    J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623
    [Abstract] [Full Text] [Related]

  • 8. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.
    Clin Exp Immunol; 2015 Aug 01; 181(2):253-66. PubMed ID: 25845911
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531
    [Abstract] [Full Text] [Related]

  • 10. Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus.
    Hu H, Chen E, Li Y, Zhu X, Zhang T, Zhu X.
    Biol Trace Elem Res; 2018 Aug 15; 184(2):391-397. PubMed ID: 29159556
    [Abstract] [Full Text] [Related]

  • 11. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice.
    Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P.
    Eur J Immunol; 2000 Feb 15; 30(2):438-47. PubMed ID: 10671199
    [Abstract] [Full Text] [Related]

  • 12. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
    Wang ZH, Zhang W, Zhang YQ, Pang CY, Wang YF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct 18; 48(5):771-776. PubMed ID: 27752154
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic targeting of BET protein BRD4 delays murine lupus.
    Wei S, Sun Y, Sha H.
    Int Immunopharmacol; 2015 Dec 18; 29(2):314-319. PubMed ID: 26590112
    [Abstract] [Full Text] [Related]

  • 14. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.
    Arthritis Rheum; 2011 Mar 18; 63(3):738-48. PubMed ID: 21305501
    [Abstract] [Full Text] [Related]

  • 15. HDAC expression and activity is upregulated in diseased lupus-prone mice.
    Regna NL, Vieson MD, Gojmerac AM, Luo XM, Caudell DL, Reilly CM.
    Int Immunopharmacol; 2015 Dec 18; 29(2):494-503. PubMed ID: 26471208
    [Abstract] [Full Text] [Related]

  • 16. Roles of interferon-gamma and interleukin-4 in murine lupus.
    Peng SL, Moslehi J, Craft J.
    J Clin Invest; 1997 Apr 15; 99(8):1936-46. PubMed ID: 9109438
    [Abstract] [Full Text] [Related]

  • 17. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, Ueda A, Shirai A, Okuda K, Miyazaki J, Ishigatsubo Y.
    Cytokine; 2000 Jul 15; 12(7):1035-41. PubMed ID: 10880249
    [Abstract] [Full Text] [Related]

  • 18. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY.
    J Exp Med; 1996 Apr 01; 183(4):1447-59. PubMed ID: 8666903
    [Abstract] [Full Text] [Related]

  • 19. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L, Sun L, Wu H, Zhang L, Chen M, Liu J, Zhong R.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):230-7. PubMed ID: 23712004
    [Abstract] [Full Text] [Related]

  • 20. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
    Hadj-Slimane R, Chelbi-Alix MK, Tovey MG, Bobé P.
    J Interferon Cytokine Res; 2004 Dec 05; 24(12):717-28. PubMed ID: 15684739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.